Cancer (Journal Of The American Cancer Society)

New England Journal of Medicine

Thursday, September 27, 2012

If Hockey Won't Fight Cancer, Hockey Fans Will : The Hockey Writers:A great cause intiated by my colleague at The Hockey Writers, Ross Bonander who is also a healthcare journalist.Excerpt:"The other day I wrote “Who Fights Cancer in a Lockout?” at Overtime, noting that should the lockout cancel games in October, it also cancels the biggest charity initiative of the NHL season, “Hockey Fights Cancer” (HFC). This means that the league, the players, and the fans won’t take part in the league-wide initiative, resulting in about $1 million not going to cancer charities this year.Well if the NHL won’t do it, and the NHLPA can’t do it, then we the fans should.To that end, I’ve created a grassroots fundraising team with the Livestrong Foundation entitled “Hockey Fans Fight Cancer.”100 % of donations go to Livestrong.

100 % of donations go straight to Livestrong, meaning your donation never changes hands except from you to them.

The NHL can afford to act leisurely. Cancer patients cannot. As a cancer care advocate for people diagnosed with blood disorders, and as someone who has lost somebody close to me to cancer, I can vouch for that reality. If you prefer to donate to another charity, like Susan G. Komen or Prostate Cancer Canada or the Pancreatic Cancer Action Network, please do.

This is a chance to show the world that the bottom-line driven, fan-neglected choices made by NHL ownership don’t define us as a fan base."

Sunday, September 23, 2012

More Breast Cancer Treatments Hinted in Study - NYTimes.com: "In findings that are fundamentally reshaping the scientific understanding of breast cancer, researchers have identified four genetically distinct types of the cancer. And within those types, they found hallmark genetic changes that are driving many cancers.These discoveries, published online on Sunday in the journal Nature, are expected to lead to new treatments with drugs already approved for cancers in other parts of the body and new ideas for more precise treatments aimed at genetic aberrations that now have no known treatment.The study is the first comprehensive genetic analysis of breast cancer, which kills more than 35,000 women a year in the United States. The new paper, and several smaller recent studies, are electrifying the field.“This is the road map for how we might cure breast cancer in the future,” said Dr. Matthew Ellis of Washington University, a researcher for the study."

"Ingenuity brought Gleevec to life, but money was a key player. It didn’t buy a cure, it bought the many expenses associated with getting there.

Organization or industry-led fundraising initiatives against cancer or any disease generally come from personal exposure. The most obvious example for hockey fans is the Mario Lemieux Foundation. Mario created the Foundation in 1993, the same year he was diagnosed with early-stage Hodgkin’s lymphoma, the same year he was cured of Hodgkin’s by radiotherapy, and the same year he won the Art Ross Trophy by scoring 39-65-104 points in 40 games before his diagnosis and 30-26-56 points in the 20 games following treatment.

The contributions made to the fight against cancer by the Mario Lemieux Foundation over the past 20 years are by any measure extraordinary, but arguably the most extraordinary is yet to come. The Mario Lemieux Center for Blood Cancers at the Hillman Cancer Center is scheduled to open this winter. It will change the otherwise complicated and frustrating journey of blood cancer patients as profoundly as Mario changed hockey."

Journal of Clinical Oncology Current Issue

The Lancet Oncology

European Journal of Cancer - Articles in Press

Journal of Oncology Pharmacy Practice current issue

About Onco-PRN

Welcome and thanks for visiting Onco-P.R.N. - The oncology website with a focus on all things oncology pharmacy/pain/palliative care-related. It is intended to be an information resource for those pharmacist and relevant health care professionals involved in whatever fashion with cancer and palliative care. Stay tuned for the latest and greatest links and information with respect to: oncology medications, continuing education, pharmaceutical care initiatives, pain and symptom control, supportive care topics, and whatever else that might fit into the theme.

*Note: This website is not affiliated with Alberta Health Services (AHS) or CAPhO and the opinions expressed herewithin are that of the author(s).

Pharmacy History

"The earliest known compilation of medicinal substances was ARIANA the Sushruta Samhita, an Indian Ayurvedic treatise attributed to Sushruta in the 6th century BC. However, the earliest text as preserved dates to the 3rd or 4th century AD.Many Sumerian (late 6th millennium BC - early 2nd millennium BC) cuneiform clay tablets record prescriptions for medicine.[3]

Ancient Egyptian pharmacological knowledge was recorded in various papyri such as the Ebers Papyrus of 1550 BC, and the Edwin Smith Papyrus of the 16th century BC.

The earliest known Chinese manual on materia medica is the Shennong Bencao Jing (The Divine Farmer's Herb-Root Classic), dating back to the 1st century AD. It was compiled during the Han dynasty and was attributed to the mythical Shennong. Earlier literature included lists of prescriptions for specific ailments, exemplified by a manuscript "Recipes for 52 Ailments", found in the Mawangdui tomb, sealed in 168 BC. Further details on Chinese pharmacy can be found in the Pharmacy in China article."

Journal of Palliative Medicine - Table of Contents

Traditional Romanian Pharmacy

The Sibiu Pharmacy Museum in Sibiu, Transylvania, Romania, is housed in a 1569 Gothic townhouse where the oldest pharmacy in Romania operated for over 150 years. The pharmacy was known as La Ursul Negru (The Black Bear).

Sir William Osler: "It is much more important to know what sort of a person has a disease than what sort of disease a patient has."

William Osler is regarded as McGill’s most eminent medical graduate and, as Professor of the Institutes of Medicine, the most eminent member of the McGill Medical Faculty. At the time of his death (1919), he was without question the best known and best loved physician in the English-speaking world.